Position in GSK
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$33,664,750
-$662,709 QoQ
Shares Held
642,212
+3.3% QoQ
Ownership
0.032%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#52
of 1,032 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 89%
Shared 0%
None 11%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026STIFEL FINANCIAL CORP holds $5,426,093,696 across 17 Drug Manufacturers - General names. GSK ranks #12 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
4,454,737 | $1,131,369,551 | |
| 2 | MRK |
Merck & Co., Inc.
|
8,169,394 | $1,049,767,127 | |
| 3 | LLY |
ELI LILLY & Co
|
786,902 | $943,833,942 | |
| 4 | ABBV |
AbbVie Inc.
|
3,625,155 | $912,234,002 | |
| 5 | AMGN |
Amgen Inc
|
1,548,229 | $560,644,681 | |
| 6 | PFE |
Pfizer Inc
|
9,980,325 | $240,326,222 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
1,152,519 | $145,609,245 | |
| 8 | AZN |
Astrazeneca PLC
|
670,847 | $127,206,004 |
All Filings in GSK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $33,664,750 | 642,212 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $34,327,459 | 621,987 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $41,006,951 | 836,194 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $38,197,502 | 885,021 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $34,054,117 | 886,826 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $24,713,909 | 637,943 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $20,907,961 | 618,213 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $24,731,294 | 604,973 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $21,234,020 | 551,533 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $25,021,201 | 583,653 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $23,622,226 | 637,405 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $25,019,965 | 690,206 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $26,079,282 | 731,742 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $25,822,324 | 725,754 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $22,982,155 | 654,017 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $18,378,354 | 624,477 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $29,810,896 | 698,242 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $28,014,064 | 655,704 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $27,126,466 | 627,154 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $22,588,578 | 602,742 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $19,802,012 | 507,023 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $23,839,424 | 681,034 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $22,630,874 | 627,008 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $26,661,348 | 722,191 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $24,729,940 | 618,143 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $25,451,078 | 684,859 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||